Assoc Prof Ravindran Kanesvaran on how new cancer drug list impacts treatment plans

Assoc Prof Ravindran Kanesvaran on how new cancer drug list impacts treatment plans

CNA·2022-09-03 00:57

Measures are in place to continue supporting cancer patients, especially for those being treated with drugs not on a new cancer drug list. Associate Professor Ravindran Kanesvaran, chairperson of the Cancer Treatment Fund Committee, shared more on how the list impacts cancer treatment.Subscribe to our channel here: https://cna.asia/youtubesub Subscribe to our news service on Telegram: https://cna.asia/telegramFollow us:CNA: https://cna.asiaCNA Lifestyle: http://www.cnalifestyle.com Facebook: https://www.facebook.com/channelnewsasiaInstagram: https://www.instagram.com/channelnewsasiaTwitter: https://www.twitter.com/channelnewsasia

Health